Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump
published in: Blood
date of publication: 2004-07-13
language: English
main subject: breast cancer, imatinib
Cites articles 1
Date
Title
Article - wd:Q33204719